Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Table 2

Disease activity of RA at baseline and follow-up period.

	Baseline	3 months	6 months	12 months	18 months	24 months
Tender joints (0–28)	24	2	2	10	2	1
Swollen joints (0–28)	10	4	0	6	0	0
ESR (mm/h)	52	3	7	8	7	11
Global Health score (0–100)	80	50	40	60	40	60
DAS28 score	7.81	2.82	2.71	4.75	2.71	3.08
Prednisolone dose (mg/day)	10	2.5	2.5	2.5	0	0